Literature DB >> 17702846

Activation of nuclear factor-kappaB by high molecular weight and globular adiponectin.

Fred Haugen1, Christian A Drevon.   

Abstract

Adipose tissue secretes a wide range of hormones named adipokines, and these may play a role in obesity-related inflammation. Adiponectin is an exceptional adipokine because low plasma concentrations are associated with obesity, type 2 diabetes, and cardiovascular diseases. It has been observed that plasma adiponectin concentrations are elevated during inflammatory conditions like preeclampsia and arthritis. Nuclear factor-kappaB (NF-kappaB) is an essential transcription factor for expression of inflammation-related proteins. We have used U937 cells stably transfected to express luciferase under the control of NF-kappaB to examine if adiponectin may modulate NF-kappaB activity. Physiological concentrations of native adiponectin induced NF-kappaB activity. This effect was relatively strong compared with proinflammatory adipokines like leptin, resistin, and IL-6. The enhanced NF-kappaB activity was attributed to the high molecular weight adiponectin isoforms. NF-kappaB was not activated by mutated adiponectin that is unable to form high molecular weight complexes. Furthermore, the C-terminal fragment, globular adiponectin, markedly increased NF-kappaB reporter activity, cytokine release, and mRNA expression of inflammation marker genes, at higher levels than stimulation with TNF-alpha and lipopolysaccharide. NF-kappaB activation by globular adiponectin was not affected by antibody inhibition of toll-like receptor 4 or TNF receptors 1 and 2 but was attenuated by inhibitors of p38 MAPK, phosphatidylinositol 3-kinase, and protein kinase C. Analyses of the p65 subunit of NF-kappaB in different leukocyte cell lines showed activation of two monocytic cell lines (U937 and THP-1) by native and globular adiponectin. Our results indicate that adiponectin has proinflammatory properties in monocytic cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17702846     DOI: 10.1210/en.2007-0370

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  53 in total

1.  Distribution of adiponectin multimeric forms in Chinese women with polycystic ovary syndrome and their relation to insulin resistance.

Authors:  Tao Tao; Edmond P Wickham; Wuqiang Fan; Jiejin Yang; Wei Liu
Journal:  Eur J Endocrinol       Date:  2010-06-07       Impact factor: 6.664

2.  Adiponectin protects endothelial cells from the damages induced by the intermittent high level of glucose.

Authors:  Xinhua Xiao; Yuanyuan Dong; Jing Zhong; Renxian Cao; Xiang Zhao; Gebo Wen; Jianghua Liu
Journal:  Endocrine       Date:  2011-09-24       Impact factor: 3.633

3.  Pulmonary inflammation induced by subacute ozone is augmented in adiponectin-deficient mice: role of IL-17A.

Authors:  David I Kasahara; Hye Y Kim; Alison S Williams; Norah G Verbout; Jennifer Tran; Huiqing Si; Allison P Wurmbrand; Jordan Jastrab; Christopher Hug; Dale T Umetsu; Stephanie A Shore
Journal:  J Immunol       Date:  2012-04-02       Impact factor: 5.422

4.  Genome-wide gene expression analysis identifies K-ras as a regulator of alcohol intake.

Authors:  Vez Repunte-Canonigo; Lena D van der Stap; Jihuan Chen; Valentina Sabino; Ulrich Wagner; Eric P Zorrilla; Gunter Schumann; Amanda J Roberts; Pietro Paolo Sanna
Journal:  Brain Res       Date:  2010-04-10       Impact factor: 3.252

5.  Adiponectin modulates DCA-induced inflammation via the ROS/NF-κ B signaling pathway in esophageal adenocarcinoma cells.

Authors:  Rong Zhang; Xiaoran Yin; Haitao Shi; Jie Wu; Pramod Shakya; Dong Liu; Jun Zhang
Journal:  Dig Dis Sci       Date:  2013-10-05       Impact factor: 3.199

6.  Role and regulation of adipokines during zymosan-induced peritoneal inflammation in mice.

Authors:  Maria Pini; Melissa E Gove; Joseph A Sennello; Jantine W P M van Baal; Lawrence Chan; Giamila Fantuzzi
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

Review 7.  Mouse models for liver cancer.

Authors:  Latifa Bakiri; Erwin F Wagner
Journal:  Mol Oncol       Date:  2013-02-05       Impact factor: 6.603

8.  Full-length adiponectin attenuates insulin signaling and inhibits insulin-stimulated amino Acid transport in human primary trophoblast cells.

Authors:  Helen N Jones; Thomas Jansson; Theresa L Powell
Journal:  Diabetes       Date:  2010-02-11       Impact factor: 9.461

9.  Evidence that adiponectin receptor 1 activation exacerbates ischemic neuronal death.

Authors:  John Thundyil; Sung-Chun Tang; Eitan Okun; Kausik Shah; Vardan T Karamyan; Yu-I Li; Trent M Woodruff; Stephen M Taylor; Dong-Gyu Jo; Mark P Mattson; Thiruma V Arumugam
Journal:  Exp Transl Stroke Med       Date:  2010-08-11

Review 10.  Adiponectin signaling in the liver.

Authors:  Terry P Combs; Errol B Marliss
Journal:  Rev Endocr Metab Disord       Date:  2014-06       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.